Cytoreductive prostatectomy: what is the evidence? A systematic review

被引:9
|
作者
Albisinni, Simone [1 ]
Aoun, Fouad [2 ,3 ]
Diamand, Romain [1 ]
Al-Hajj Obeid, Walid [1 ,4 ]
Porpiglia, Francesco [5 ]
Roumeguere, Thierry [1 ]
De Nunzio, Cosimo [6 ]
机构
[1] Univ Libre Bruxelles, Hop Erasme, Univ Clin Brussels, Dept Urol, Brussels, Belgium
[2] Univ Libre Bruxelles, Univ Clin Brussels, Inst Jules Bordet, Dept Urol, Brussels, Belgium
[3] St Joseph Univ, Hotel Dieu France, Dept Urol, Beirut, Lebanon
[4] St George Hosp, Univ Med Ctr, Dept Urol, Beirut, Lebanon
[5] Univ Turin, San Luigi Gonzaga Hosp, Dept Urol, Turin, Italy
[6] Sapienza Univ Rome, St Andrea Hosp, Dept Urol, Rome, Italy
关键词
Prostatic neoplasms; Neoplasm metastasis; Prostatectomy; Cytoreduction surgical procedures; ANDROGEN-DEPRIVATION THERAPY; RADICAL PROSTATECTOMY; PHASE-II; METASTATIC NICHE; CANCER; FEASIBILITY; DOCETAXEL; CELLS; TUMOR; BONE;
D O I
10.23736/S0393-2249.18.03319-2
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
INTRODUCTION: Cytreductive prostatectomy is an experimental surgical approach to metastatic prostate cancer (mPCa), with the scope of improving local symptoms and potentially ameliorate oncologic outcomes. Aim of the current systematic review is to analyze available evidence to support this approach and explore published data a future trial on cytoreductive prostatectomy. EVIDENCE ACQUISITION: A systematic review was conducted searching all relevant studies published in PubMed, EMBASE, Cochrane Library, CINAHL, Google Scholar and Ovid database until August 1, 2018. A search was performed including the combination of following words: "cytoreductive" AND "prostatectomy" AND "prostate" AND "cancer"). Of the 49 initial papers identified, 28 were excluded after screening by the authors, leaving 21 articles eligible for the review. EVIDENCE SYNTHESIS: In vitro and in vivo models support the concept of removing the primary tumor, considered a "sanctuary site," in order to reduce the metastatic potential of prostate cancer. Large retrospective population studies have reported improved oncologic outcomes for men undergoing cytoreductive prostatectomy, though such results are limited by the retrospective design and major selection biases. Little evidence from well designed prospective trials is available, yet a net improvement of overall survival has not been reported. Nonetheless, most studies reported a reduction of local complications after cytoreductive prostatectomy (<10%) compared to best systemic therapy (25-30%). Prospective randomized trials are underway: their results will help elucidate the true impact of cytoreductive prostatectomy on oncologic outcomes of mPCa. CONCLUSIONS: Although supported from a biological point of view and albeit encouraging results of population-based studies, cytoreductive remains to date experimental. A true benefit on overall survival of mPCa is not supported by current evidence. The results of prospective trials are eagerly awaited.
引用
收藏
页码:1 / 8
页数:8
相关论文
共 50 条
  • [1] Cytoreductive prostatectomy in metastatic prostate cancer: a systematic review
    Becker, Joachim Aidt
    Berg, Kasper Drimer
    Roder, Martin Andreas
    Brasso, Klaus
    Iversen, Peter
    SCANDINAVIAN JOURNAL OF UROLOGY, 2018, 52 (01) : 1 - 7
  • [2] A systematic review of cytoreductive prostatectomy outcomes and complications in oligometastatic disease
    Morozov, Andrey
    Chuvalov, Leonid
    Taratkin, Mark
    Enikeev, Mikhail
    Rapoport, Leonid
    Singla, Nirmish
    Barret, Eric
    Poddubskaya, Elena
    Borodina, Maria
    Salomon, Georg
    Rivas, Juan Gomez
    Enikeev, Dmitry
    ASIAN JOURNAL OF UROLOGY, 2024, 11 (02) : 208 - 220
  • [3] Cytoreductive prostatectomy: Evidence in Support of a new surgical paradigm (Review)
    Faiena, Izak
    Singer, Eric A.
    Pumill, Chris
    Kim, Isaac Y.
    INTERNATIONAL JOURNAL OF ONCOLOGY, 2014, 45 (06) : 2193 - 2198
  • [4] An Updated Systematic and Comprehensive Review of Cytoreductive Prostatectomy for Metastatic Prostate Cancer
    Yanagisawa, Takafumi
    Rajwa, Pawel
    Kawada, Tatsushi
    Bekku, Kensuke
    Laukhtina, Ekaterina
    Deimling, Markus von
    Majdoub, Muhammad
    Chlosta, Marcin
    Karakiewicz, Pierre I.
    Heidenreich, Axel
    Kimura, Takahiro
    Shariat, Shahrokh F.
    CURRENT ONCOLOGY, 2023, 30 (02) : 2194 - 2216
  • [5] A SYSTEMATIC REVIEW OF CYTOREDUCTIVE PROSTATECTOMY OUTCOMES AND COMPLICATIONS IN PATIENTS WITH OLIGOMETASTATIC PROSTATE CANCER
    Morozov, Andrey
    Chuvalov, Leonid
    Enikeev, Mikhail
    Taratkin, Mark
    Enikeev, Dmitry
    JOURNAL OF UROLOGY, 2021, 206 : E364 - E365
  • [6] What Is the Evidence for "Food Addiction?" A Systematic Review
    Gordon, Eliza L.
    Ariel-Donges, Aviva H.
    Bauman, Viviana
    Merlo, Lisa J.
    NUTRIENTS, 2018, 10 (04)
  • [7] A systematic review and meta-analysis of comparative studies on the efficacy of cytoreductive prostatectomy in patients with metastatic prostate cancer
    Zhao, Yan
    Peng, Dashuai
    Liang, Jie
    Lin, Yingli
    Qi, Jingguang
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE, 2020, 13 (02): : 330 - 339
  • [8] A systematic review on Richter syndrome: what is the published evidence?
    Molica, Stefano
    LEUKEMIA & LYMPHOMA, 2010, 51 (03) : 415 - 421
  • [9] Geriatric day hospital: what evidence? A systematic review
    Petermans, Jean
    Velghe, Anja
    Gillain, Daniel
    Boman, Xavier
    Van den Noortgate, Nele
    GERIATRIE ET PSYCHOLOGIE NEUROPSYCHIATRIE DE VIEILLISSEMENT, 2011, 9 (03): : 295 - 303
  • [10] Kinesiotaping for postoperative oedema – what is the evidence? A systematic review
    Julie Hörmann
    Werner Vach
    Marcel Jakob
    Saskia Seghers
    Franziska Saxer
    BMC Sports Science, Medicine and Rehabilitation, 12